Sockeye salmon are a significant part of the cultural, social, and economic fabric of British Columbia (BC). Responsible stewardship of wild sockeye salmon fisheries is becoming increasingly important as human pressures and environmental changes intensify. One of the key challenges in sustainable salmon management is the ability to identify and protect at risk populations within a mixed stock fishery. BC’s…
Read More
Two weeks ago, a two-year-old with tooth decay started exhaling alarming amounts of CO2 and her heart began to race three minutes after being put under general anesthesia for a routine cleaning at the dentist’s office. Aware they were looking at a potentially fatal reaction to the anesthetic, the team administered fentanyl, then cut the anesthesia and quickly started an…
Read More
B.C.’s biotechnology sector has emerged as a critical arm of the province’s pandemic response. As a result, this has been a rare year where funding and resources are not in question. In the coming days, the B.C. Centre for Disease Control aims to increase its surveillance to screen every new COVID-19-positive sample for the presence of those variants of the…
Read More

Streamlining Clinical Research in BC to Tackle COVID-19

The race to find treatment approaches to improve patient outcomes and end the COVID-19 pandemic has involved the coordination of research teams and patients across British Columbia. At the helm of this undertaking is the COVID-19 Clinical Research Coordination Initiative (CRCI), of which Vancouver Coastal Health Research Institute (VCHRI) scientist Dr. Theodore Steiner is a member. “The CRCI facilitates clinical research…
Read More
The Michael Smith Foundation for Health Research (MSFHR) and the BC Academic Health Science Network (BC AHSN) have signed a Memorandum of Understanding to join forces to create a dynamic and integrated health research organization that will support the growth and evolution of BC’s research and life sciences sectors. The proposed new organization will be committed to improving the health…
Read More
Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation for CHK-336, an investigational oral small molecule inhibitor of lactate dehydrogenase A (LDHA) for primary hyperoxaluria (PH). PH is a group (PH1, PH2 and PH3)…
Read More

Bright Minds Biosciences Announces Listing on Canadian Stock Exchange

Bright Minds Biosciences, a biosciences company focused on creating the next generation of psychedelic and related therapies for the treatment of mental health and central nervous system disorders, today announced that the Company’s common shares (the “Shares”) are expected to commence trading on the Canadian Securities Exchange (the “CSE”) on Monday, February 8, 2021, under the ticker symbol “DRUG.” Bright…
Read More
LRRK2 is a highly studied gene in Parkinson’s disease, where increased activity is thought to play a causative role. Now, new research has established that decreased LRRK2 expression can be involved in the development of lung adenocarcinoma. With inhibitors of LRRK2 now in clinical trials for the treatment of Parkinson’s disease, the discovery that LRRK2 loss can increase lung tumour initiation comes at a key point in time. The…
Read More
Unlike the U.S. or Europe, where vaccines from Moderna Inc. and Pfizer Inc. are produced, Canada does not possess wide-scale vaccine manufacturing capacity of its own. Since December, the country has been totally reliant on foreign manufacturers — a reality that’s been highlighted amid ongoing Moderna and Pfizer shortages. In the years to come, though, it will be a Vancouver…
Read More
Precision NanoSystems, Inc. (PNI), a global leader in technologies and solutions for development of genetic medicines, announced today that it has received a contribution of CAD $25.1 million through the Strategic Innovation Fund (SIF). This contribution will support a CAD $50.2-million project to establish a biomanufacturing centre in Vancouver dedicated to the production of ribonucleic acid (RNA) lipid nanoparticle vaccines…
Read More